Literature DB >> 1269839

Arginine-stimulated hyperglucagonemia in diabetic Pima Indians.

S L Aronoff, P H Bennett, N B Rushforth, M Miller, R H Unger.   

Abstract

Groups of 27 nondiabetic Pima Indians, 34 nondiabetic Caucasians, and 12 diabetic Pima Indians with recent onset of their disease received an arginine infusion to determine if (1) nondiabetic Pima Indians and Caucasians had a similar glucagon response to arginine and (2) diabetic Pimas had excessive glucagon response to arginine as reported in other racial groups. The fasting glucagon levels in the three groups were not significantly different. During arginine monochloride infusion (5 mg./kg./minute for 40 minutes) the diabetic Pimas had glucagon levels significantly higher at 10 minutes and at all sampling points thereafter than the normo-glycemic Pimas. Plasma insulin levels also increased during the infusion but, notably, never differed significantly between these two groups. There was no significant difference in the glucagon levels at any sampling point between the nondiabetic Pimas and Caucasians. The differences in glucagon levels between the nondiabetic and diabetic Indians are similar to those differences reported between diabetic and nondiabetic subjects of other racial origins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269839     DOI: 10.2337/diab.25.5.404

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function.

Authors:  R Assan; S Efendic; R Luft; E Cerasi
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

2.  GLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in rats.

Authors:  M Ohneda; J H Johnson; L R Inman; R H Unger
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.